NDC 70121-1569 – Releuko

Filgrastim 300 ug/mL · Injection, Solution · Intravenous, Subcutaneous

Human Prescription Drug

Product NDC70121-1569

Product details

Brand name
Releuko
Generic name
Filgrastim
Labeler
Amneal Pharmaceuticals LLC
Dosage form
Injection, Solution
Route
Intravenous, Subcutaneous
Marketing category
BLA · BLA761082
Marketed since
February 25, 2022
Listing expires
December 31, 2026
Pharmacologic class
Leukocyte Growth Factor

Active ingredients

Uses, dosage, side effects and warnings for Releuko →

Package NDC codes (1)

Package NDCDescriptionSince
70121-1569-710 VIAL in 1 PACKAGE (70121-1569-7) / 1 mL in 1 VIALFeb 25, 2022

Other Releuko products